NCT01808248 Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3 Status COMPLETED Phase PHASE2
NCT01807208 PLATFORM to Maximize Patient Knowledge of Health Goals After Acute Myocardial Infarction Status COMPLETED Phase NA
NCT01804543 Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy Status UNKNOWN Phase N/A
NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01801293 A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 Status COMPLETED Phase PHASE1
NCT01799889 Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT01797445 Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults Status COMPLETED Phase PHASE3
NCT01797419 Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) Status WITHDRAWN Phase PHASE1
NCT01796470 Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT01793649 A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects Status TERMINATED Phase PHASE1
NCT01790633 Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests Status COMPLETED Phase NA
NCT01783678 A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults Status COMPLETED Phase PHASE3
NCT01780506 Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults Status COMPLETED Phase PHASE3
NCT01779518 Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C Status APPROVED_FOR_MARKETING Phase N/A
NCT01779505 A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults Status COMPLETED Phase PHASE1
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting Status COMPLETED Phase PHASE4
NCT01772121 Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India Status COMPLETED Phase N/A
NCT01769456 An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) Status COMPLETED Phase PHASE2
NCT01769196 Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01768286 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection Status COMPLETED Phase PHASE3